Anti-Müllerian hormone as a sensitive marker of ovarian function in young cancer survivors

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Krawczuk Rybak, Maryna ^a   Leszczynska, Elzbieta ^a   Poznanska, Marta ^a   Zelazowska Rutkowska, Beata ^a   Wysocka, Jolanta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893848172     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/125080     Document Type: Article

References (30)

1. Wallace W. H. B., Anderson R. A., Irvine D. A., Fertility preservation for young patients with cancer: who is at risk and what can be offered? The Lancet Oncology 2005 6 4 209 218 2-s2.0-28044435608 10.1016/S1470-2045(05)70092- 9 (Pubitemid 40450712)
2. Sklar C. A., Mertens A. C., Mitby P., Whitton J., Stovall M., Kasper C., Mulder J., Green D., Nicholson H. S., Yasui Y., Robison L. L., Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. Journal of the National Cancer Institute 2006 98 13 890 896 2-s2.0-33745782947 10.1093/jnci/djj243 (Pubitemid 44018918)
3. Lantinga G. M., Simons A. H. M., Kamps W. A., Postma A., Imminent ovarian failure in childhood cancer survivors. European Journal of Cancer 2006 42 10 1415 1420 2-s2.0-33745140237 10.1016/j.ejca.2006.01.016 (Pubitemid 43903149)
4. Fong S. L., Laven J. S. E., Hakvoort-Cammel F. G. A. J., Schipper I., Visser J. A., Themmen A. P. N., de Jong F. H., van den Heuvel-Eibrink M. M., Assessment of ovarian reserve in adult childhood cancer survivors using anti-müllerian hormone. Human Reproduction 2009 24 4 982 990 2-s2.0-64949131988 10.1093/humrep/den487
5. Borgmann-Staudt A., Rendtorff R., Reinmuth S., Hohmann C., Keil T., Schuster F. R., Holter W., Ehlert K., Keslova P., Lawitschka A., Jarisch A., Strauss G., Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence. Bone Marrow Transplantation 2012 47 2 271 276 2-s2.0-84857033069 10.1038/bmt.2011.78
6. Singh K. L., Davies M., Chatterjee R., Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing. Human Reproduction Update 2005 11 1 69 89 2-s2.0-13444272139 10.1093/humupd/dmh052 (Pubitemid 40201977)
7. Anderson R. A., Nelson S. M., Wallace W. H. B., Measuring anti-müllerian hormone for the assessment of ovarian reserve: when and for whom is it indicated? Maturitas 2012 71 1 28 33 2-s2.0-84855459917 10.1016/j.maturitas.2011.11.008
8. Broer S. L., Eijkemans M. J. C., Scheffer G. J., van Rooij I. A. J., de Vet A., Themmen A. P. N., Laven J. S. E., de Jong F. H., Te Velde E. R., Fauser B. C., Broekmans F. J. M., Anti-müllerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. Journal of Clinical Endocrinology and Metabolism 2011 96 8 2532 2539 2-s2.0-79961233799 10.1210/jc.2010-2776
9. Brougham M. F. H., Wallace W. H. B., Subfertility in children and young people treated for solid and haematological malignancies. The British Journal of Haematology 2005 131 2 143 155 2-s2.0-32944481385 10.1111/j.1365-2141.2005. 05740.x (Pubitemid 43899679)
10. Green D. M., Sklar C. A., Boice J. D. Jr., Mulvihill J. J., Whitton J. A., Stovall M., Yasui Y., Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the childhood cancer survivor study. Journal of Clinical Oncology 2009 27 14 2374 2381 2-s2.0-65549170424 10.1200/JCO.2008.21.1839
11. Shebl O., Ebner T., Sir A., Schreier-Lechner E., Mayer R. B., Tews G., Sommergruber M., Age-related distribution of basal serum AMH level in women of reproductive age and a presumably healthy cohort. Fertility and Sterility 2011 95 2 832 834 2-s2.0-78751580339 10.1016/j.fertnstert.2010.09.012
12. Visser J. A., de Jong F. H., Laven J. S. E., Themmen A. P. N., Anti-müllerian hormone: a new marker for ovarian function. Reproduction 2006 131 1 1 9 2-s2.0-32544458177 10.1530/rep.1.00529 (Pubitemid 43230697)
13. Hagen C. P., Aksglaede L., Sørensen K., Main K. M., Boas M., Cleemann L., Holm K., Gravholt C. H., Andersson A., Pedersen A. T., Petersen J. H., Linneberg A., Kjaergaard S., Juul A., Serum levels of anti-müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 turner syndrome patients. Journal of Clinical Endocrinology and Metabolism 2010 95 11 5003 5010 2-s2.0-78049492520 10.1210/jc.2010-0930
14. Miyoshi Y., Ohta H., Namba N., Tachibana M., Miyamura T., Miyashita E., Hashii Y., Oue T., Isobe A., Tsutsui T., Kimura T., Ozono K., Low serum concentrations of anti-müllerian hormone are common in 53 female childhood cancer survivors. Hormone Research in Paediatrics 2013 79 1 17 21 10.1159/000346139
15. Fong S. L., Lugtenburg P. J., Schipper I., Themmen A. P. N., de Jong F. H., Sonneveld P., Laven J. S. E., Anti-müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies. Human Reproduction 2008 23 3 674 678 2-s2.0-40749097721 10.1093/humrep/dem392 (Pubitemid 351651205)
16. Behringer K., Breuer K., Reineke T., May M., Nogova L., Klimm B., Schmitz T., Wildt L., Diehl V., Engert A., Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's lymphoma study group. Journal of Clinical Oncology 2005 23 30 7555 7564 2-s2.0-32944474118 10.1200/JCO.2005.08.138 (Pubitemid 46291819)
17. Giuseppe L., Attilio G., Edoardo D. N., Loredana G., Cristina L., Vincenzo L., Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). Hematology 2007 12 2 141 147 2-s2.0-34247183723 10.1080/10245330600954072 (Pubitemid 46605523)
18. de Bruin M. L., Huisbrink J., Hauptmann M., Kuenen M. A., Ouwens G. M., van 't Veer M. B., Aleman B. M. P., van Leeuwen F. E., Treatment-related risk factors for premature menopause following Hodgkin lymphoma. Blood 2008 111 1 101 108 2-s2.0-38049126114 10.1182/blood-2007-05-090225
19. van Beek R. D., van den Heuvel-Eibrink M. M., Laven J. S. E., de Jong F. H., Themmen A. P. N., Hakvoort-Cammel F. G., van den Bos C., van den Berg H., Pieters R., de Muinck Keizer-Schrama S. M. P. F., Anti-müllerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. Journal of Clinical Endocrinology and Metabolism 2007 92 10 3869 3874 2-s2.0-35349021476 10.1210/jc.2006-2374 (Pubitemid 47607635)
20. Larsen E. C., Müller J., Rechnitzer C., Schmiegelow K., Andersen A. N., Diminished ovarian reserve in female childhood cancer survivors with regular menstrual cycles and basal FSH <10 IU/l. Human Reproduction 2003 18 2 417 422 2-s2.0-0037326140 10.1093/humrep/deg073 (Pubitemid 36236279)
21. Gnaneswaran S., Deans R., Cohn R. J., Reproductive late effects in female survivors of childhood cancer. Obstetrics and Gynecology International 2012 2012 7 564794 10.1155/2012/564794
22. Schuck A., Hamelman V., Brämswig J. H., Könemann S., Rübe C., Hesselmann S., Riesenbeck D., Horst E., Bölling T., Paulussen M., Jürgens H., Willich N., Ovarian function following pelvic irradiation in prepubertal and pubertal girls and young adult women. Strahlentherapie und Onkologie 2005 181 8 534 539 2-s2.0-23044483912 10.1007/s00066-005-1367-x
23. Wallace W. H. B., Thomson A. B., Kelsey T. W., The radiosensitivity of the human oocyte. Human Reproduction 2003 18 1 117 121 2-s2.0-0037250894 10.1093/humrep/deg016 (Pubitemid 36138861)
24. Bath L. E., Wallace W. H. B., Shaw M. P., Fitzpatrick C., Anderson R. A., Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-müllerian hormone, inhibin B and ovarian ultrasound. Human Reproduction 2003 18 11 2368 2374 2-s2.0-0242438564 10.1093/humrep/deg473 (Pubitemid 37427819)
25. Balcerek M., Reinmuth S., Hohmann C., Keil T., Borgmann-Staudt A., Suspected infertility after treatment for leukemia and solid tumors in childhood and adolescence. Deutsches Ärzteblatt International 2012 109 7 126 131 2-s2.0-84857990140 10.3238/arztebl.2012.0126
26. Brougham M. F., Crofton P. M., Johnson E. J., Evans N., Anderson R. A., Wallace W. H., Anti-müllerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study. Journal of Clinical Endocrinology and Metabolism 2012 97 6 2059 2067 10.1210/jc.2011-3180
27. Bath L. E., Anderson R. A., Critchley H. O. D., Kelnar C. J. H., Wallace W. H. B., Hypothalamic-pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia. Human Reproduction 2001 16 9 1838 1844 2-s2.0-0034809185 (Pubitemid 32916209)
28. Ebbiary N. A. A., Lenton E. A., Cooke I. D., Hypothalamic-pituitary ageing: progressive increase in FSH and LH concentrations throughout the reproductive life in regularly menstruating women. Clinical Endocrinology 1994 41 2 199 206 2-s2.0-0027971058 (Pubitemid 24239924)
29. Larsen E. C., Müller J., Schmiegelow K., Rechnitzer C., Andersen A. N., Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. Journal of Clinical Endocrinology and Metabolism 2003 88 11 5307 5314 2-s2.0-10744220220 10.1210/jc.2003-030352 (Pubitemid 37452732)
30. Hamre H., Kiserud C. E., Ruud E., Thorsby P. M., Fossa S. D., Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study. Pediatric Blood and Cancer 2012 59 2 271 277 10.1002/pbc.23363